Get started

Shortsqueeze

AMC Start of a New Run?30 Minute Chart As you can see, previously we dipped down 17% from $39 to $32. Then we went from $32 all the way to our current highs of $48 around a 50% gain. We have now seen a drop of around 17% from $48 to $40. MACD is also showing signs of crossover to upside. RSI showing a similar trend which we have hit the 30 level on RSI. In both RSI patterns we have seen a bounce back to the overbought region (+70 RSI). if we continue this pattern we could see another similar run up around 50% which would make for a 20 pt move from $40 to $60. Please let me know what you guys think ! All comments welcome. Leave a like if you enjoyed this setup.
NYSE:AMCLong
by Smarter_Trades
5
$Aso, High probability short squeeze by swing tradingThe stock is holding at the area of 42.69. it's no right time for an entry, as the stock is extended from it's 5 & 10 period moving average where we expect the price to consolidate or pull back producing a right entry at the are of 42.69, the stock is highly correlated with the General market and should be traded with high caution. stock can be traded in daily, hourly or any other intraday time frame as per your style of trading. if anything, please do drop a comment below. thank you. Real time trade with educational purpose, please don't forget to do your homework.
NASDAQ:ASOLong
by localogist
There's a riot coming... Short Squeeze on RIOTWith a Short Interest of 26% and an active attempt to squeeze the shorts it looks like RIOT could see a volatile move upwards supported by reasonable fundamentals, Bitcoins recent price action, and technical indicators that suggest a reversal. Setting up to break out of a descending channel/wedge. F-Score is a 5 with some indication the books may be cooked so this likely isn't a buy & hold. Price target & stop loss recommendation put this at a 6:1 risk to reward ratio. Timeline is days to weeks. Watch for a position Monday morning around 10:30am.
NASDAQ:RIOTLong
by jsgiardino
$ESPR Short squeeze - 1 D Candle I think ESPR could start to get interested in this level . - After a long decline from the peak ($ 40) this year, on 27/1/2021, we are now witnessing a consolidation in the price level. - I do not look at fundamental information, only technical data . Indicators : * EMA21 is the purple line * EMA9 is the green line * Consolidation at Slow Stochastic * RSI begins to change direction - 26.23M short float (low float) - Setup: Falling Wedge - Short floating percentage 32.48% - Above the consolidation at 15$ squeeze can happen * It can be very aggressive .. think of all the Short's sellers who will have to cover positions after they see a price level break after consolidation ... * No financial advice just my personal opinion, make your own DD!
NASDAQ:ESPRLong
by SaTLla101
Writing The SCPS?SCPS seeing another spike in trading volume late in the week (week of 8/1). After plotting out the fib retracement using "normal levels" and not ones from the crazy parabolic spike previously, you can see this 618 area has been a key support/resistance level. With the latest spark taking SCPS stock higher afterhours on 8/4, it so far managed to break back above the 618 area for the first time in weeks. No news, no filings, just social momo. But thanks to it being part of that "low float" crowd, it could be in the mix of possible "short squeeze stocks" that've grown in popularity. Looking at the deets...back in May there were a few fundamental developments to track: " the company announced that it received FDA approval for an Investigational New Drug Application for its lead drug candidate, CpG-STAT3siRNA. Now, a Phase 1 trial for B-cell non-Hodgkin lymphoma will begin at the City of Hope. This is a well-known research and treatment center for cancer, diabetes, and other diseases. More To Watch With SCPS Stock As a newer company, Scopus has only been public since December of 2020. The company initially raised just under $3 million from its IPO debut. While this wasn’t technically a penny stock initially, shares hovered around $5 earlier this month. That was, until the news on May 24th. Since the announcement, SCPS stock has surged past the $17 mark. Furthermore, even though it’s a newer company, analysts have also begun following the company closely. Benchmark Research started Scopus with a Speculative Buy rating as well as a price target of $20. Analyst Aydin Huseynov believes that the company’s STAT3 inhibitor gene therapy, CO-sTiRNA, has “a reasonable chance to show clinically relevant results” in recurrent and hard-to-treat aggressive Non-Hodgkin Lymphoma indications. Huseynov gave this outlook several months before today’s news and expected the IND submission during the second half of the year. " Quote Source & Read More: 3 Biotech Penny Stocks To Watch That Analysts Are Bullish On Today
S
by PennyStocks101
$TAOP STRONG CLOSE!!! ;) -Traded this in the morning on friday but this failed to breakout that $4.25 wall that's #1 so the momentum is there but volume needs to kick in -As we closed on friday we had a very strong close and candles like these don't get left hanging -Tis is very strong resistance think of it like a rubber band the more you test its resistance the more it will shoot. -This has massive potential you now the worse that can happen is that this is a pull back to more lows... set a tight stop play smart... theres basically no loss as long as you manage it correctly
NASDAQ:TAOPLong
by Ubaidy100
Buy the rumor... sell the newsBITFINEX:BTCUSD is coming off its rally now on the denial from Amazon NASDAQ:AMZN that it will not accept Bitcoin. Prior to this the run up has been labeled a "short squeeze" as that term has become all the rage in 2021. It did in fact qualify as one seeing as how over 60% of leveraged short positions have cleared out in the bullish move. From a contrarian perspective... clearing out the leveraged shorts actually increases the probability that a break of the consolidation lows (sub 30k) will induce a violent "long squeeze."
BITFINEX:BTCUSD
by norok
10